Mativ delivered one of its strongest quarters since its formation three years ago, with sales increasing 3.0% year over year to $513.7 million and adjusted EBITDA rising 10% to $66.8 million. The company achieved its highest adjusted EBITDA margin since the 2022 merger at 13% and significantly improved free cash flow to $66.7 million, up 179% from the prior year.

Mativ delivered solid second-quarter results with a slight increase in sales and a 1% rise in Adjusted EBITDA year-over-year. The company achieved its second-highest cash flow quarter since the merger, driven by organic volume growth in the SAS segment and disciplined cost control. Despite some unfavorable pricing and higher manufacturing costs, the company's focus on cash flow and working capital optimization yielded strong results.

Mativ reported a net loss of $425.5 million for the first quarter of 2025, primarily due to a non-cash goodwill impairment charge of $411.9 million. Sales decreased by 3.1% year over year to $484.8 million. Adjusted EBITDA was $37.2 million, down 19% from the prior year.

Mativ Holdings, Inc. reported a 1.4% increase in sales year-over-year for Q4 2024, reaching $458.6 million, with organic growth of 4.3%. GAAP income improved significantly to $1.5 million from a loss in the prior year, while Adjusted EBITDA decreased by 10% due to lower volumes in Advanced Films and higher input costs, partially offset by growth in other product categories and reduced SG&A.

Mativ reported a slight increase in sales and a significant improvement in GAAP loss for Q3 2024. Sales increased by 0.1% year over year, and GAAP loss improved by $443.5 million compared to the prior year. Adjusted EBITDA was up 10% versus the prior year.

Mativ's second quarter results reflect strong adjusted EBITDA and margin growth, driven by favorable relative net selling price vs. input cost performance, increased volume and improved operating performance. Sales decreased slightly by 0.5% year-over-year to $523.8 million, but increased 4.7% sequentially versus Q1 2024.

Mativ reported a decrease in sales compared to the prior year, but experienced sequential volume recovery. The company's GAAP loss included organizational realignment, integration, and purchase accounting expenses. Adjusted EBITDA was slightly lower than the previous quarter due to higher cost inventories.

Mativ reported Q4 2023 results with sales of $452.3 million, a GAAP loss of $13.6 million, and adjusted EPS of $0.23. The company faced headwinds from customer de-stocking and persistent inflation, but made progress in debt reduction and synergy realization. They divested Engineered Papers, reduced debt by over 35%, consolidated sites, and achieved targeted Merger synergies ahead of plan.

Mativ reported a decrease in sales by 9.7% to $498.2 million. The company had a GAAP loss of $464.3 million, which included a non-cash goodwill impairment charge of $401.0 million. Adjusted EPS was $0.21, and Adjusted EBITDA was $55.4 million, down 20% versus the prior year.

Mativ's second quarter results showed strong sequential EBITDA growth, driven by improved manufacturing execution, cost reductions, synergy realization, and positive price/cost performance. Sales increased due to the merger, but were offset by an organic sales decline. The company announced the proposed sale of Engineered Papers and a rebalanced capital allocation strategy.

Mativ reported a 66.9% increase in sales to $679.0 million, reflecting the merger's benefit. However, the company experienced a GAAP loss of $7.7 million, with GAAP EPS at $(0.14). Adjusted EPS was $0.25. The quarter was affected by customer de-stocking, labor strikes in France, and manufacturing inefficiencies, which pressured margins.

Mativ reported a 69% increase in sales to $660.1 million, driven by the merger and 6% constant currency organic sales growth. However, the company experienced a GAAP loss of $2.5 million, with a GAAP EPS of $0.04, due to significant expenses related to the Neenah merger integration. Adjusted EPS was $0.56, and Adjusted EBITDA increased by 30% on a comparable basis.

Mativ Holdings, Inc. reported a 76% increase in sales to $674.1 million, driven by strong growth in release liners, protective solutions, filtration, and paper and specialty packaging. GAAP EPS was $(0.43), while adjusted EPS was $0.74. The company expects 4Q:22 Adjusted EBITDA to be consistent with 3Q:22 Adjusted EBITDA of $93.0 million and continued year-over-year Adjusted EBITDA growth into 2023.

Mativ Holdings, Inc. reported a sales increase of 13% to $426.4 million with organic sales growth of 11%. GAAP EPS was $0.36, up from $0.06, while adjusted EPS was $0.86, down 4%. The company announced 2H:22 Adjusted EBITDA guidance of $210 to $230 million (on combined basis) and a $1.60 annualized quarterly cash dividend per share.

SWM International reported a 40% increase in total sales to $390.4 million, with a 3% organic increase. GAAP EPS was $1.68, which included a gain on asset sale and favorable tax items. Adjusted EPS was $0.36, down from $0.77. The company issued 2022 Adjusted EPS guidance of $3.50 to $3.95, driven by 20% to 30% adjusted EBITDA growth.

SWM International reported a 37.3% increase in total sales to $383.6 million, but a 1% decrease on an organic basis. GAAP operating profit was $23.0 million, down $14.0 million, while adjusted operating profit was $40.0 million, down $12.7 million. GAAP EPS was $0.38, down from $0.78, and adjusted EPS was $0.82, down from $1.16. Management expects full year 2021 adjusted EPS to finish below the previously provided guidance range.

SWM's Q2 2021 results showed strong demand with organic sales growth in AMS and sales increase in EP, but were impacted by significant input cost inflation and supply chain challenges. The Scapa acquisition, closed in April 2021, is performing as expected.

SWM announced a strong quarter with sales and adjusted profit growth in both segments. The company's diversified portfolio delivered growth throughout the varying conditions in an economic cycle. Adjusted EPS grew 15%, exceeding expectations.

SWM reported a 6% decrease in total sales to $254.2 million but demonstrated portfolio resilience with stable Engineered Papers segment profits and Advanced Materials & Structures segment performance despite COVID-19 impacts. Adjusted EPS was $0.90, reflecting solid execution and overall resilience.